Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals.
Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals.
复制标题
COVID-19在专业临床服务中的评估:1325个人中的12个月,单一中央的前瞻性研究。
DOI:
10.1136/bmjresp-2021-001041
复制
发表时间:
2021-11
影响因子:
4.1
通讯作者:
Banerjee A
中科院分区:
文献类型:
--
作者:
Heightman M;Prashar J;Hillman TE;Marks M;Livingston R;Ridsdale HA;Bell R;Zandi M;McNamara P;Chauhan A;Denneny E;Astin R;Purcell H;Attree E;Hishmeh L;Prescott G;Evans R;Mehta P;Brennan E;Brown JS;Porter J;Logan S;Wall E;Dehbi HM;Cone S;Banerjee A
Post-COVID-19 complications require simultaneous characterisation and management to plan policy and health system responses. We describe the 12-month experience of the first UK dedicated post-COVID-19 clinical service to include hospitalised and non-hospitalised patients. In a single-centre, observational analysis, we report the demographics, symptoms, comorbidities, investigations, treatments, functional recovery, specialist referral and rehabilitation of 1325 individuals assessed at the University College London Hospitals post-COVID-19 service between April 2020 and April 2021, comparing by referral route: posthospitalised (PH), non-hospitalised (NH) and post emergency department (PED). Symptoms associated with poor recovery or inability to return to work full time were assessed using multivariable logistic regression. 1325 individuals were assessed (PH: 547, 41.3%; PED: 212, 16%; NH: 566, 42.7%). Compared with the PH and PED groups, the NH group were younger (median 44.6 (35.6–52.8) years vs 58.3 (47.0–67.7) years and 48.5 (39.4–55.7) years), more likely to be female (68.2%, 43.0% and 59.9%), less likely to be of ethnic minority (30.9%, 52.7% and 41.0%) or seen later after symptom onset (median (IQR): 194 (118–298) days, 69 (51–111) days and 76 (55–128) days; all p<0.0001). All groups had similar rates of onward specialist referral (NH 18.7%, PH 16.1% and PED 18.9%, p=0.452) and were more likely to require support for breathlessness (23.7%, 5.5% and 15.1%, p<0.001) and fatigue (17.8%, 4.8% and 8.0%, p<0.001). Hospitalised patients had higher rates of pulmonary emboli, persistent lung interstitial abnormalities and other organ impairment. 716 (54.0%) individuals reported <75% optimal health (median 70%, IQR 55%–85%). Less than half of employed individuals could return to work full time at first assessment. Post-COVID-19 symptoms were significant in PH and NH patients, with significant ongoing healthcare needs and utilisation. Trials of interventions and patient-centred pathways for diagnostic and treatment approaches are urgently required.
登录
查看更多内容
影响因子:
9.1
作者:
Oronsky B;Larson C;Hammond TC;Oronsky A;Kesari S;Lybeck M;Reid TR
通讯作者:
Reid TR
DOI:
10.1016/j.jcmg.2021.04.011
发表时间:
2021-11
期刊:
JACC. Cardiovascular imaging
影响因子:
--
作者:
Joy G;Artico J;Kurdi H;Seraphim A;Lau C;Thornton GD;Oliveira MF;Adam RD;Aziminia N;Menacho K;Chacko L;Brown JT;Patel RK;Shiwani H;Bhuva A;Augusto JB;Andiapen M;McKnight A;Noursadeghi M;Pierce I;Evain T;Captur G;Davies RH;Greenwood JP;Fontana M;Kellman P;Schelbert EB;Treibel TA;Manisty C;Moon JC;COVIDsortium Investigators
通讯作者:
COVIDsortium Investigators
影响因子:
64.8
作者:
Al-Aly, Ziyad;Xie, Yan;Bowe, Benjamin
通讯作者:
Bowe, Benjamin
影响因子:
3.6
作者:
Parkin A;Davison J;Tarrant R;Ross D;Halpin S;Simms A;Salman R;Sivan M
通讯作者:
Sivan M
影响因子:
15.1
作者:
Raman B;Cassar MP;Tunnicliffe EM;Filippini N;Griffanti L;Alfaro-Almagro F;Okell T;Sheerin F;Xie C;Mahmod M;Mózes FE;Lewandowski AJ;Ohuma EO;Holdsworth D;Lamlum H;Woodman MJ;Krasopoulos C;Mills R;McConnell FAK;Wang C;Arthofer C;Lange FJ;Andersson J;Jenkinson M;Antoniades C;Channon KM;Shanmuganathan M;Ferreira VM;Piechnik SK;Klenerman P;Brightling C;Talbot NP;Petousi N;Rahman NM;Ho LP;Saunders K;Geddes JR;Harrison PJ;Pattinson K;Rowland MJ;Angus BJ;Gleeson F;Pavlides M;Koychev I;Miller KL;Mackay C;Jezzard P;Smith SM;Neubauer S
通讯作者:
Neubauer S